PDS Biotechnology Corp — Director's Dealing 2019

Jul 1, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PDS Biotechnology Corp (PDSB)
CIK: 0001472091
Period of Report: 2019-06-28

Reporting Person: Glover Steve C (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-06-28	Stock Option (Right to Buy)	$5.99	A	9000	Acquired	2029-06-28	Common Stock (9000)	Direct

Footnotes

F1: One third of the shares underlying the option shall vest upon each of the first, second, and third anniversaries of the date of grant, such that the option will be fully vested on June 28, 2022.